Monitoring the evolution of the SARS-CoV-2 virus
ACTIV TRACE support at NCBI for SARS-CoV-2
This study is looking at how the COVID-19 virus changes over time to find out about new variants, which could help improve treatments and vaccines for everyone affected by the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | A-Tek, INC. NIH-funded |
| Lab location | 1 site (Mclean, United States) |
| Project ID | NIH-10936614 on NIH RePORTER |
What this research studies
This research focuses on tracking the genetic changes in the SARS-CoV-2 virus, which causes COVID-19. By evaluating how the virus evolves, the study aims to identify different variants and understand their potential effects on treatments and vaccines. Patients may benefit from this research as it could lead to improved medical countermeasures against COVID-19 variants. The approach involves genomic analysis and characterization of the virus to inform public health strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been infected with COVID-19 or are at risk of infection, particularly those in areas with high transmission rates.
Not a fit: Patients who have not been infected with COVID-19 or those who are not at risk of exposure may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance the effectiveness of vaccines and treatments for COVID-19 by providing insights into viral evolution.
How similar studies have performed: Other research has successfully monitored viral evolution in similar contexts, indicating that this approach is both tested and valuable.
Where this research is happening
Mclean, United States
- A-Tek, INC. — Mclean, United States (Active)
Researchers
- Principal investigator: Freeland, Kathryn — A-Tek, INC.
- Study coordinator: Freeland, Kathryn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.